Parkinson’s Disease (PD) is diagnosed based on classical motor symptoms, including…
Category: Clinical Trials
Home / Clinical Trials /
When designing pediatric clinical drug trials, it’s important to work with…
Children are not little adults, but due to a lack of…
In the pharmaceutical and biotechnology industry more small and even virtual…
Did you know that only about 20 percent of drugs used…
Shoulder to shoulder with our clients, we at QPS like to…
Two companies have just selected QPS Netherlands to conduct their First-in-Human…
An investigation into the efficacy and safety of Estetrol (E4) for…
Patient recruitment is one of the most critical foundations of any…
QPS has been assisting an international Sponsor to perform a global,…
QPS has been assisting an international Sponsor to perform a global,…
The European Medicines Agency (EMA) has released a draft guideline revision…
Making the right decision about where to conduct Phase I of…
Okay, we’ll admit it: a company telling you about their new…
QPS was able to deliver on this extremely challenging early phase…
The sheer abundance of diet drugs available suggests two things: 1)…
In July 2015, regulatory expert Patricia Baede joined QPS’ clinical development…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
QPS Selects Ryght AI as an Exclusive AI Partner for Clinical Trial Optimization and Automation while adding to Ryght’s global site network. Laguna Beach,…
NEWARK, Delaware, November 13, 2024/BUSINESS WIRE/ — QPS Holdings, LLC announced today that their Springfield campus, QPS Missouri, has launched a new Cell Therapy…
NEWARK, Delaware, June 26, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), is pleased to announce new laboratory…
Webinars
Using Video Games for Early Detection of Parkinson’s Disease
August 3, 2020
Parkinson’s Disease (PD) is diagnosed based on classical motor symptoms, including bradykinesia (slowed movement and loss of spontaneous movement), muscular rigidity, resting tremors and postural
Working with Families in Pediatric Clinical Drug Trials
October 1, 2019
When designing pediatric clinical drug trials, it’s important to work with the entire family to ensure the experience is convenient, comfortable, and rewarding. If certain
Guidance for Scheduling Clinical Trials in Children
September 24, 2019
Children are not little adults, but due to a lack of pediatric clinical trials, children are often prescribed drugs that have only been approved for
New Horizons for Patient Studies at QPS-NL
September 13, 2019
In the pharmaceutical and biotechnology industry more small and even virtual companies are established thereby changing the traditional way of working in early drug development.
Solutions for Recruitment for Pediatric Clinical Trials
September 3, 2019
Did you know that only about 20 percent of drugs used today are labeled for pediatric patients? By necessity, products licensed for adults are often
Spreading Early Clinical Knowledge
October 20, 2017
Shoulder to shoulder with our clients, we at QPS like to share the results of our early clinical research efforts, published in the scientific literature.
QPS Tapped for Two New FIH Studies
May 5, 2017
Two companies have just selected QPS Netherlands to conduct their First-in-Human studies. Acticor Biotech, a Paris-based biotechnology company focused on the treatment of acute ischemic
QPS Study Shows Estetrol Promising for Prostate Cancer Treatment
May 2, 2017
An investigation into the efficacy and safety of Estetrol (E4) for potential use in the treatment of advanced prostate cancer demonstrated decreased testosterone levels along
QPS’ Patient Recruitment Management at the 2016 Annual Meeting of the Clinical Trials Community in Israel
May 4, 2016
Patient recruitment is one of the most critical foundations of any clinical trial. Effective patient recruitment sets the trial down a path toward success if
QPS Global Clinical Operations Team Aces Enrollment for a Global Study of a Prostate Cancer Drug
April 19, 2016
QPS has been assisting an international Sponsor to perform a global, late-phase study to investigate the safety, efficacy, and pharmacokinetic behavior of an investigational drug
QPS Global Clinical Operations Team Aces Enrollment for Global Study of Prostate Cancer Drug and Completes the First Patient in Europe!
March 2, 2016
QPS has been assisting an international Sponsor to perform a global, late-phase study to investigate the safety, efficacy, and pharmacokinetic behavior of a newly formulated
Consultation open on revised EMA Guideline on Medicines to treat Alzheimer’s Disease
February 15, 2016
The European Medicines Agency (EMA) has released a draft guideline revision on the clinical investigation of medicines for the treatment of Alzheimer’s disease and other
Read the QPS Whitepaper on Phase I Site Selection to support EU Registration
January 6, 2016
Making the right decision about where to conduct Phase I of a clinical trial is crucial. As long as basic EU regulatory requirements are fulfilled,
Specialized, Collaborative Clinical Development Services Provide Peace of Mind for Clients
August 18, 2015
Okay, we’ll admit it: a company telling you about their new brochure seems about as interesting as looking through your Great Uncle’s vacation pictures –
First-in-Human, Safety, Tolerability, PK and PD Study of a Rapid Onset Anesthetic: QPS Plays It Safe!
August 28, 2015
QPS was able to deliver on this extremely challenging early phase clinical trial because we have access to the expertise of a university anaesthesiology department
Dr. Diane Krieger from QPS MRA acknowledged in NEJM for her role as investigator in the SCALE Obesity and Prediabetes Study Group
July 27, 2015
The sheer abundance of diet drugs available suggests two things: 1) there is a huge market for them and 2) none of them work significantly
Regulatory Expertise Now Part of QPS Clinical Development Offerings
July 9, 2015
In July 2015, regulatory expert Patricia Baede joined QPS’ clinical development teams. With 20 years of experience in clinical trial conduct and all regulatory aspects
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
QPS Selects Ryght AI as an Exclusive AI Partner for Clinical Trial Optimization and Automation while adding to Ryght’s global site network. Laguna Beach,…
NEWARK, Delaware, November 13, 2024/BUSINESS WIRE/ — QPS Holdings, LLC announced today that their Springfield campus, QPS Missouri, has launched a new Cell Therapy…
NEWARK, Delaware, June 26, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), is pleased to announce new laboratory…
